NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 82 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2014. The put-call ratio across all filers is 179.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $130,000 | 0.0% | 137,458 | +40.9% | 0.00% | 0.0% |
Q4 2015 | $130,000 | -40.1% | 97,558 | +2.4% | 0.00% | 0.0% |
Q3 2015 | $217,000 | +41.8% | 95,316 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $153,000 | -13.1% | 95,316 | -14.0% | 0.00% | 0.0% |
Q1 2015 | $176,000 | -20.0% | 110,800 | -4.9% | 0.00% | 0.0% |
Q4 2014 | $220,000 | +42.9% | 116,490 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $154,000 | -9.4% | 116,490 | +1.4% | 0.00% | 0.0% |
Q2 2014 | $170,000 | -1.7% | 114,838 | +22.7% | 0.00% | 0.0% |
Q1 2014 | $173,000 | -10.8% | 93,603 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $194,000 | -23.0% | 93,603 | -1.4% | 0.00% | 0.0% |
Q3 2013 | $252,000 | +11.0% | 94,935 | +11.8% | 0.00% | 0.0% |
Q2 2013 | $227,000 | – | 84,936 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Platinum Management (NY) LLC | 10,375,329 | $13,549,000 | 19.76% |
Catalyst Capital Advisors LLC | 790,000 | $1,635,000 | 0.53% |
DSC Advisors, L.P. | 500,000 | $1,035,000 | 0.50% |
STONERIDGE INVESTMENT PARTNERS LLC | 142,528 | $295,000 | 0.06% |
Hudock, Inc. | 30,500 | $63,000 | 0.05% |
BRR OpCo, LLC | 52,700 | $109,000 | 0.05% |
TFS CAPITAL LLC | 418,074 | $865,000 | 0.04% |
LifePlan Financial Group, Inc | 28,810 | $60,000 | 0.04% |
NOMURA HOLDINGS INC | 3,831,177 | $7,947,000 | 0.04% |
BOLTON LP | 77,400 | $160,000 | 0.03% |